Immune changes and their relationship with prognosis in patients with varicella-zoster virus encephalitis/meningitis.

Yanrong Yuan,Yan Zhang,Jun Wang,Huili Liu,Hua Zhang,Yongxing Yan

2023-01-01

American journal of translational research

Abstract:These immune changes were compromised in VZV encephalitis/meningitis. The peripheral CD3+ and CD4+ levels may be employed to predict prognosis.

What problem does this paper attempt to address?

Cerebrospinal Fluid Proteomics in Meningitis Patients with Reactivated Varicella Zoster Virus

Huili Liu,Jun Wang,Yan Zhang,Jing Gu,Yu Wang,Yongxing Yan,Dongli Pan,Zeyu Sun

DOI: https://doi.org/10.1002/iid3.1038

2023-01-01

Abstract:Objective: This study investigated the proteomic characteristics of cerebrospinal fluid (CSF) in patients with varicella zoster virus (VZV) meningitis to understanding the pathogenesis of central nervous system (CNS) infection by reactivated VZV.Method: We used data-independent acquisition model to analyze the CSF proteomic differences of 28 patients with VZV meningitis and 11 herpes zoster (HZ) patients. According to the clinical manifestations at discharge, 28 VZV meningitis patients were divided into favorable outcome group and unfavorable outcome (UO) group and their differences in CSF proteome were also analyzed.Results: Compared with the HZ group, the proteins (CXCL10, ELANE, IL-1RN, MPO, PRTN3, etc.) related to inflammation and immune cell activation were significantly upregulated in the VZV meningitis group (p < .01). The protein related to the nerve function and energy metabolism (CKMT1B, SLITRK3, Synaptotagmin-3, KIF5B, etc.) were significantly downregulated (p < .05). The levels of a pro-inflammatory factor, IL-18, in CSF were significantly higher in patients in the UO group as compared to patients with favorable prognosis (p < .05).Conclusion: Inflammatory immune response is an important pathophysiological mechanism of CNS infection by VZV, and the CSF IL-18 levels might be a potential prognostic indicator of the outcomes of VZV meningitis.
Factors Predictive of Varicella Zoster Virus Encephalitis/Meningitis: A Single-Center, Retrospective Study

Yanrong Yuan,Jun Wang,Yan Zhang,Huili Liu,Yongxing Yan

DOI: https://doi.org/10.12659/MSM.938057

2022-01-01

Medical Science Monitor

Abstract:Background: The outcomes of varicella zoster virus (VZV) encephalitis/meningitis vary from complete recovery to severe complications. This study aimed to investigate the predictive factors of encephalitis and meningitis caused by VZV reactivation. Material/Methods: VZV encephalitis/meningitis patients (n=39) who were treated between January 2019 and December 2021 were included. Patients were followed up for 3 months after discharge and divided into a favorable outcome group (FO, n=18; 46.2%) and an unfavorable outcome group (UO, n=21; 53.8%) according to whether it affects quality of life. The clinical data were retrospectively analyzed and compared between groups. Results: As compared to the FO group, patients in the UO group were more likely to have higher body temperature (>38 degrees C) at admission, longer interval from onset of CNS symptoms to initial of antiviral therapy, higher white blood cells (WBC) and adenosine deaminase (ADA) in the cerebrospinal fluid (CSF) and higher CRP in the blood (P<0.05 or P<0.01). Univariate logistic regression analysis showed CSF ADA (OR=1.279, 95% CI: 0.996 similar to 1.642) and interval from onset of CNS symptoms to initial of antiviral therapy (0R=1.299, 95% CI: 1.011 similar to 1.669) were independent risk factors for unfavorable outcomes (P<0.05). The sensitivity and specificity of combined CSF ADA and time interval from onset of CNS symptoms to initial of antiviral therapy were 78.8% and 95.2%, respectively, in predicting outcomes. Conclusions: Higher CSF ADA and longer interval from onset of CNS symptoms to initial of antiviral therapy predict an unfavorable outcome, and the combination of both factors can achieve better performance.
Dynamic Immune Landscape and VZV-Specific T Cell Responses in Patients with Herpes Zoster and Postherpetic Neuralgia

Qiao Peng,Xuejiao Guo,Yang Luo,Guocan Wang,Lingyu Zhong,Jiamin Zhu,Yunze Li,Xun Zeng,Zhiying Feng

DOI: https://doi.org/10.3389/fimmu.2022.887892

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:ObjectivesVaricella-zoster virus (VZV) can induce herpes zoster (HZ) and postherpetic neuralgia (PHN). Immune cells play an important role in regulating HZ and PHN pathogenesis, but the dynamic immune profiles and molecular mechanisms remain unclear. This study aimed to screen dynamic immune signatures during HZ progression and elucidate the mechanism of VZV-specific T cells in PHN.MethodsWe used cytometry by time-of-flight (CyTOF) to analyze peripheral blood mononuclear cells (PBMC) samples from 45 patients with HZ and eight age-sex-matched healthy controls, eight PHN samples and seven non-PHN samples. Correlations between the immune subsets and clinical pain-related scores were performed. Further, the characteristics of VZV-specific T cells between PHN and non-PHN patients were evaluated by VZV peptide pools stimulation. The expression level of cytokines, including granzyme B, interleukin (IL)-2, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α was performed via cytometric bead array. Finally, we analyzed the alteration of Ca2+ signals in dorsal root ganglion (DRG)-derived cells after TNF-α stimulation.ResultsWe investigated the dynamic characteristics of the immune landscape of peripheral blood samples of patients with HZ and PHN, and depicted two major dynamic signatures in NK, CD4+ and CD8+ T subsets in patients with HZ, which closely correlated with clinical pain-related scores. The frequency of PD-1+CD4+ T cells, VZV-specific PD-1+CD4+ T cells, and the amount of TNF-α produced by VZV-specific T cells were higher in patients with PHN than without PHN. Furthermore, we showed that TNF-α could induce calcium influx in DRG-derived cells in a dose-dependent manner.ConclusionsOur results profiled the dynamic signatures of immune cells in patients with HZ and highlighted the important role of VZV-specific T cells in the pathogenesis of PHN.
Meningitis/meningoencephalitis Caused by Varicella Zoster Virus Reactivation: a Retrospective Single-Center Case Series Study.

Yongxing Yan,Yanrong Yuan,Jun Wang,Yan Zhang,Huili Liu,Zuyong Zhang

2022-01-01

Abstract:Recent clinical studies showed that central nervous system (CNS) infection caused by varicella zoster virus (VZV) reactivation was more than previously reported. The clinical manifestations were often diverse and complex, and the outcome often varied among different patients. A systematic study is needed to provide clinical characteristics of the CNS VZV infection to help clinicians with clinical diagnosis and management. Toward that end, we retrospectively analyzed the clinical presentations, laboratory results, imaging findings, treatment and outcomes in74 patients with meningitis or meningoencephalitis caused by VZV reactivation in our center from August 2018 to December 2020. Fever, headache, cranial nerve involvement, cognitive changes, meningeal irritation, nausea, vomiting, and Ramsay-Hunt syndrome (RHS) were the most common clinical manifestations of VZV meningitis or meningoencephalitis. Brain MRI analysis showed no obvious abnormal manifestation. Compared to VZV meningoencephalitis, patients with VZV meningitis were younger (56.9±13.8 vs 66.1±8.5 years; P=0.01), and more likely to develope in winter (P=0.04), had lower cerebrospinal fluid (CSF) glucose content (3.68±0.79 vs 4.21±0.94 mmol/L, P=0.02), and a better outcome at discharge (P=0.00). The outcome at discharge was worse in male patients and when longer than 1.5 days passed between onset of the neurological symptoms to initiation of the antiviral treatment.Early intravenous antiviral treatment for VZV meningitis and meningoencephalitis is important and is expected for a good outcome.
The Correlation Between Clinical Severity and Lymphocyte Subsets or Immunoglobulin Subtypes in Patients with Herpes Zoster

Qiong TIAN,Juanjuan XUE,Tianyuan GAO,Wenli LIU,Xin MU,Rui GE,Lijuan WANG,Jian ZHANG

DOI: https://doi.org/10.13735/j.cjdv.1001-7089.201707085

2018-01-01

Abstract:Objective To explore the correlation between severity of clinical symptoms and lymphocyte cell or immunoglobulin-related indicators in patients with herpes zoster(HZ), and to provide a new idea for prognosis prediction, diagnosis and treatment of HZ. Methods We selected 91 HZ inpatients who were treated in Department of Dermatology,from September 2016 to March 2017. According to the clinical symptoms, the patients were divided into two groups:mild to moderate group(n =41) and severe group (n = 50). The percentage of T lymphocytes of each subtype were detected at the time of admission and immunoglobin was subjected to genotyping assay. Results The CD4 +/CD8 + index of severe group(2.46 ±0.83) wass higher than mild to moderate group (2.01 ±0.91 ). The IgE index of severe group (59.78 ±41.74) IU/mL was lower than that in mild to moderate group(83.14 ±51.38) IU/mL. There was no significant difference in IgA,IgM and IgG index between the two groups ( P＞0.05 ). The IgG2 index of severe group (4.40 ± 1.93) g/L was higher than that in mild to moderate group(3.59 ± 1.52)g/L. The ratio of IgG subtypes was investigated. The index of ln( IgGl/IgG2) of mild to moderate group(0.787 ±0.341) was higher than that in severe group (0.641 ±0.307). In addition, the index of ln( IgG3/IgG4) was higher in mild to moderate group (-0.146 ±0.102) than in severe group (-0.274 ±0.115). Conclusion There are some correlations between severity of clinical symptoms and lymphocyte cells or immunoglobulin antibody in HZ patients. Some sensitive indexes are required for differential diagnosis and outcome prediction for HZ.
Serum Immunoglobulin G Level and Neutrophils to Lymphocytes Ratio Associated with the Prognosis of Neuromyelitis Optica Spectrum Disorder.

Ying Tong,Li Wang,Kai Liu,Weishi Liu,Shen Li,Bo Song,Zongping Xia,Yuming Xu,Rui Zhang

DOI: https://doi.org/10.2174/1567202618666210702113526

2021-01-01

Current Neurovascular Research

Abstract:OBJECTIVE:To investigate the factors related to the prognosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) in cerebrospinal fluid and peripheral blood examination.METHODS:In this study, we enrolled 111 patients who were admitted to the First Affiliated Hospital of Zhengzhou University between January 2016 and January 2018 and diagnosed with NMOSD. The patients were divided into the relapse group (n = 48) and remission group (n = 67). Before treatment, all the patients underwent a routine Cerebrospinal Fluid (CSF) and peripheral blood test on the second morning of admission. The association between laboratory data and disease prognosis was evaluated.RESULTS:The immunoglobulin G (IgG) level in the serum showed a strong correlation with the relapse of patients, especially in the aquaporin-4-Antibody (AQP4-Ab) positive group (p < 0.01). A high level of serum IgG concentration was associated with the relapse of NMOSD, especially in the anti-AQP4 positive group. The area under the Receiver Operating Characteristic (ROC) curve of serum IgG level was 0.888 (p<0.001, 95%CI: 0.808-0.968). The ratio of Neutrophils to Lymphocytes (NLR) was associated with the disability degree of NMOSD patients in 3 years. The NLR value was a linear correlation with final Expanded Disability Status Scale (EDSS) scores; patients with a high level of NLR value presented an increased degree of disability in the following three years (R2 = 0.053, p= 0.015).CONCLUSION:The serum IgG level and NLR of first-attack patients were correlated with the prognosis of NMOSD.
Single-cell Immune Profiling and Validation of PBMCs in the Onset of and Recovery from Herpes Zoster

Shang Zheng,Shuyao Zhang,Xiangyao Li,Yong Fei,Lei Yang,Beibei Liu,Kangli Shen,Qinli Feng,Qinghe Zhou,Ming Yao,Longsheng Xu

DOI: https://doi.org/10.1038/s42003-024-07289-w

IF: 6.548

2024-01-01

Communications Biology

Abstract:To gain deeper insights into pathogenesis of herpes zoster, the peripheral blood mononuclear cells (PBMCs) from male patients mostly were subjected to single-cell RNA-seq (scRNA-seq) and ATAC-seq analysis. Here we show a detailed immune cell profile in the onset of and recovery from herpes zoster, revealing proportion alterations of the subpopulations, which were validated by flow cytometric analysis and comparison of blood routine data. The integrative analysis of the transcriptomes and epigenomes provided a comprehensive description and validation of the key changes in peripheral blood. This study may provide deep insight into the immune profile during herpes zoster progression and holds potential clinical significance.
Analysis of risk factors and prediction model construction for varicella encephalitis in children: A retrospective cohort study

Ce Wang,Li Tang,Dandan Guo

DOI: https://doi.org/10.1177/13596535241291132

2024-10-18

Antiviral Therapy

Abstract:CONCLUSION: Children with varicella who are older, experience vomiting, exhibit poor mental status, or have a prolonged rash duration should be closely monitored clinically. The predictive model combining these four factors demonstrates good predictive efficiency.

pharmacology & pharmacy,infectious diseases,virology
Dynamic Behavior of Lymphocyte Subgroups Correlates with Clinical Outcomes in Human H7N9 Infection.

Yu Chen,Xuefen Li,Li Tian,Shufa Zheng,Shigui Yang,Yuejiao Dong,Yiyin Wang,Dawei Cui,Xiaoli Liu,Weifeng Liang,Honglin Chen,Lanjuan Li

DOI: https://doi.org/10.1016/j.jinf.2014.05.006

2014-01-01

Abstract:OBJECTIVES:To investigate peripheral blood lymphocyte subgroups response to the H7N9 virus and identify potential correlations between the anti-viral response and clinical outcomes in infected patients.METHODS:T lymphocyte subgroups, cytokine/chemokine levels in peripheral blood and H7N9 viral loads in the sputum were measured for 53 H7N9 patients (14 lethal and 39 non-lethal cases). 22 H1N1 patients and 15 healthy volunteers were selected as controls.RESULTS:Low proportions of T cells were observed in H7N9-infected individuals, particularly those who later died, and these correlated with clinical APACHE II scores and H7N9 virus loads in sputum. T-cell levels fluctuated during hospitalization and decreased suddenly on the day of death in those who succumbed to infection, whereas a dramatic increase in lymphocyte subgroups was observed in those who survived beyond the early stage of infection, with the levels of most lymphocyte subgroups significantly higher during the recovery phase compared to the early phase of infection. A cytokine/chemokine storm was also confirmed in this study.CONCLUSIONS:H7N9-infected individuals have low proportions of peripheral blood T lymphocyte subgroups, particularly those suffering fatal infections. The numbers of CD3(+) T cells (including CD4(+) and CD8(+) T cells) may predict the clinical outcome of human H7N9 infection.
Varicella-Zoster Virus Meningitis and Encephalitis: An Understated Cause of Central Nervous System Infections

Jose C Alvarez,Jorge Alvarez,Javier Tinoco,Patricio Mellado,Hector Miranda,Marcela Ferrés,Jonathan Forero,Cristian Álvarez

DOI: https://doi.org/10.7759/cureus.11583

2020-11-20

Cureus

Abstract:Background Varicella-zoster virus (VZV) and herpes zoster cause infections of the central nervous system (CNS) manifesting as meningitis or encephalitis. As compared to enterovirus (EV) and herpes simplex virus 1 (HSV-1) and 2 (HSV-2), it is not often tested in CNS infections due to VZV and herpes zoster. There is a certain tendency to think that the findings in the cerebrospinal fluid in infections of the CNS by viruses are comparable among themselves. The exact proportion of patients with VZV primary and reactivation infection who present with lesions prior to or concomitant to its involvement in the CNS is unknown. It is also not known about the risk factors that lead to the reactivation of VZV and CNS involvement. Objective To describe the clinical characteristics and laboratory results of patients with a positive VZV polymerase chain reaction (PCR) and neurological signs and symptoms. Methods A retrospective and descriptive study was performed at the Hospital Universitario de la Pontificia Universidad Católica de Chile (Hospital Clínico UC CHRISTUS) from September 2012 to July 2014. The following parameters were recorded: neurological signs and symptoms, PCR for VZV in cerebrospinal fluid (CSF), comorbidities, personal medical history, cutaneous lesions, CSF characteristics, CNS imaging, electroencephalography (EEG), treatment, mortality, and neurological sequelae. Adult patients with meningitis, encephalitis, or meningoencephalitis due to VZV diagnosed with PCR were included. Results Out of 70 CSF samples analyzed in the previously mentioned period, 21 cases were VZV positive, 16 cases that had clinical information available were included. The mean age with VZV CNS reactivation was 47 years (range 19-80 years). Five patients (31.25%) were immunocompromised: three had human immunodeficiency virus (HIV), one had kidney transplantation, and one had primary immunodeficiency. Clinical presentation was meningitis in 11 patients (68.75%) and encephalitis in five patients (31.25%). Pleocytosis in CSF was observed in all the samples. The five immunocompromised patients had cutaneous lesions. All patients received antiviral treatment. Therapy duration was from 10 up to 21 days. The clinical course was positive in most patients and the mean hospitalization time was 15 days (range 5-60 days). No mortality was observed. Conclusions VZV is a worldwide virus and a common cause of CNS infection. The rising incidence is probably due to a better diagnostic method and a frequent clinical suspicion even in the absence of cutaneous lesions, except in immunocompromised cases, as it was observed in the present study. CNS infection presented as a wide spectrum of clinical manifestations with possible neurological sequelae. There was a reduction in neurological morbidity with antiviral therapy. Nonetheless, both the incidence and the morbidity of CNS VZV infection are expected to be diminished by varicella and herpes zoster vaccination. Additionally, there was no increase in mortality in these patients.
Challenges in Diagnosing Varicella-Zoster Virus Encephalitis in an Immunocompromised Patient

Andreana Chen,Prinka Perswani,Raj Kumari,Siddiqi M Haque,Min Zhang

DOI: https://doi.org/10.7759/cureus.65226

2024-07-23

Cureus

Abstract:Varicella-zoster virus (VZV) is a virus of the alphaherpesvirus family that is one of the common causes of infectious encephalitis worldwide, especially among those who are immunocompromised. In this case report, we discuss a case of a 55-year-old female with end-stage renal disease presenting with altered mental status and weakness. She was recently diagnosed with herpes zoster on oral acyclovir and multiple scattered dermatomal rashes on presentation. Cerebral spinal fluid analysis showed neutrophilic pleocytosis, high glucose and protein, and anti-VZV Immunoglobulin G (IgG) antibodies. She was started on treatment early with acyclovir and demonstrated good clinical improvement afterward two weeks. This case highlights to importance of performing lumbar puncture and looking for anti-VZV antibodies to rule out encephalitis in patients with altered mental status and starting acyclovir treatment early.
Varicella‑zoster virus‑associated meningitis followed peripheral facial palsy: A case report

Yaozhi Hu,Mengfei Zhong,Mengliang Hu,Ligong Zhang

DOI: https://doi.org/10.3892/etm.2024.12669

2024-07-30

Abstract:Although central nervous system infection following varicella zoster virus infection is relatively common, subsequent peripheral nervous system infection is comparatively rare. The present case documents a case of meningitis after varicella-zoster virus (VZV) infection, which was then followed by peripheral facial palsy. Specifically, a 54-year-old female patient was first admitted to Shengli Oilfield Central Hospital (Dongying, China) with headache and fever. Physical examination revealed herpes that formed along the intercostal nerve in the left forebreast, armpit and back. Subsequently, neurological examination found cervical resistance in more than three fingers (neck resistance of less than two transverse fingers is not evidence of meningeal irritation; the neck resistance of this patient was approximately three transverse fingers, so the patient was presumed to be positive for meningeal irritation, highly suggestive of meningitis) and Kernig sign was positive. There were no significant abnormalities according to brain MRI and lumbar puncture pressure was 330 mmH2O. In addition, the leukocyte count was 734x106/l, 50% monocyte count, 50% multinucleated cells, chloride levels of 109.1 mmol/l, protein levels of 235 mg/dl and glucose levels of 4.18 mmol/l in the cerebrospinal fluid. DNA and RNA metagenomic detection of pathogenic microorganisms in the cerebrospinal fluid revealed the presence of VZV. The patient was therefore treated with acyclovir, ceftriaxone, mannitol and methylprednisolone, but then developed right peripheral facial palsy at 10 days after treatment. This complication was not found in the literature, and the occurrence of facial neuritis was unexpected. The active period of VZV virus was 21 days, and the patient had herpes 5 days before admission. The active period of the virus was considered to have subsided and the patient was in the recovery period. Moreover, the results of lumbar puncture showed that the white blood cells, the proportion of neutrophils and the protein in cerebrospinal fluid were all decreasing, which also indicated that the patient had entered the recovery period. The patient was discharged 18 days after admission. In conclusion, observations from the present case suggested that the clinical manifestations of VZV infection can be complex and varied, requiring the clinician to have an accurate understanding of its disease progression and treatment.
The Role of Varicella Zoster Virus (VZV) in Central Nervous System Infectious Syndromes

Viktoria Yakovenko,Pnina Ciobotaro,Rita Bardenstein,Margalit Zusev,Oren Zimhony

DOI: https://doi.org/10.1155/cjid/6664417

2024-11-13

Abstract:Background: We describe the proportion of VZV infection in central nervous system (CNS) infectious syndromes in a single Israeli medical center. Methods: An observational cohort study was conducted in Kaplan Medical Center (a secondary hospital, Israel) between July 1, 2014, and March 31, 2019. Included were adult patients (≥ 16 years old) with CNS infection with an aseptic CSF profile that were subjected to molecular tests for herpes viruses, HSV either 1 or 2, VZV, enteroviruses, and IgM for West Nile virus (WNV). Results: Clinical presentation suggestive of CNS infection led to lumbar puncture and CSF analysis in 1500 patients yielding 178 cases with aseptic CSF profile. For 62/109 (55.9%) cases of meningitis, the etiology remained unknown, enterovirus accounted for 21 cases (18.9%), VZV for 16 (14.4%), and HSV 1 for 7 (6.3%). One case each of bacterial, fungal, and parainfluenza virus accounted for the other 3 cases. For 30/63 (47.6%) cases of encephalitis, the etiology remained unknown, HSV accounted for 11 cases (17.5%), VZV for 8 (12.7%), and WNV for 10 (15.9%); in two cases, enterovirus was identified and one case of influenza A and one of mycoplasma, accounted for the rest. In six patients with myelitis VZV was identified in 4 (66.7%). Notably, a typical herpetic rash was identified in only 11/28 (39.28%) of cases of VZV CNS infection. Conclusions: VZV is a significant cause of viral CNS infections. In the majority of patients with neurologic syndrome and evident VZV there is no association with a typical herpetic rash. These results apply to Israeli population and likely to other populations with similar background of VZV past infections.
Effect of varicella‐zoster virus infection and antiviral treatment on the risk for dementia: A meta‐analysis of observational studies

Li‐fei Zhu,Chuan‐cai Hu,Yu Mei,Min‐jing Zhu,Ting‐yun Ye

DOI: https://doi.org/10.1002/brb3.3407

IF: 3.1

2024-02-06

Brain and Behavior

Abstract:Background and purpose: There is increasing evidence to support a role for human herpes viruses in the development of neurodegenerative disorders; however, the association between varicella‐zoster virus (VZV) infection and dementia, and the effect of antiviral therapy on the risk for dementia remain unclear. Methods We searched PubMed, Embase, and the Cochrane Library databases from their dates of inception to May 2023. Odds ratios (ORs) with 95% confidence intervals (CIs) served as indicators of effect sizes in evaluations of the effect of VZV infection and antiviral treatment on dementia risk. Subgroup analyses based on study design, study location, diagnostic criteria of dementia, and VZV subtype classification were also performed. Results A total of 10 studies with 316,846 dementia cases were included in the meta‐analysis. We found that any VZV infection (OR: 1.04, 95% CI: .97–1.12; p = .22), herpes zoster (HZ) (OR: 1.05, 95% CI: .96–1.13; p = .28), or HZ involving the cranial nerves (OR: 1.36, 95% CI: .76–2.43; p = .304) was not associated with an increased risk of dementia. The results of subgroup analyses were consistent with these findings. However, patients infected with VZV who received antiviral treatment had a lower OR than untreated patients infected with VZV. Compared to individuals not infected with VZV, antiviral therapy in those infected with VZV was associated with reduced risk for dementia. Conclusion The association between VZV infection and dementia may be masked by antiviral treatment. Further studies with longer follow‐up times that consider the severity of VZV infection and antiviral treatment are needed to clarify the contribution of VZV infection to the risk for dementia.

behavioral sciences,neurosciences
Assessment of the humoral immune status of varicella-zoster virus in patients with diffuse connective tissue diseases

Xiang Sun,Yin-Shan Zang,Yan Xu,Wen Wang

DOI: https://doi.org/10.3389/fmed.2024.1470068

2024-09-05

Abstract:Background: Diffuse connective tissue diseases (DCTDs) require long-term immunosuppressive treatment, increasing the risk of varicella-zoster virus (VZV) infection. This study aims to evaluate the humoral immune status against VZV in DCTD patients and explore factors that may influence their immune levels. Methods: This is a retrospective cohort study that collected data from adult DCTD patients (≥18 years) attending our outpatient clinic. The geometric mean concentration (GMC) of VZV-specific IgG antibodies in the patients' sera was measured using the enzyme-linked immunosorbent assay (ELISA). Results: A total of 280 RA patients, 272 SLE + MCTD patients and 280 healthy controls were included. SLE + MCTD patients had significantly higher VZV IgG antibody levels than RA patients (p < 0.05) but showed no significant difference compared to healthy controls (p > 0.05). Notable differences were observed particularly among female patients and those aged 30-49 years, (p < 0.05). SLE + MCTD patients in an active disease state had significantly higher VZV IgG antibody titers than RA patients (p < 0.05). Additionally, patients with a history of herpes zoster, regardless of being in the SLE + MCTD, RA, or control group, exhibited higher VZV IgG titers (p < 0.05). Conclusion: Although DCTD patients, particularly those with SLE and MCTD, exhibit higher VZV IgG antibody levels, they still face a higher risk of developing herpes zoster (HZ), which may be related to their underlying disease and immunosuppressive treatment. The presence of antibodies alone may not provide complete protection, necessitating consideration of cellular immune mechanisms. It is recommended to enhance monitoring of VZV antibody levels in high-risk patients and consider herpes zoster vaccination to reduce HZ-related complications.
Dynamic Characteristics of Lymphocyte Subsets and Their Predictive Value for Disease Progression and Prognosis in Primary Infection and Unvaccinated COVID-19 Patients

Xinyi Zhang,Zhu Chen,Jun Zheng,Chen Feng,Bennan Zhao,Lijuan Lan,Dafeng Liu

DOI: https://doi.org/10.2147/IJGM.S478912

2024-10-10

Abstract:Aim: Our cohort study aimed to investigate the dynamic changes of lymphocyte subsets and their abilities to predict disease severity and prognosis in primary infection and unvaccinated COVID-19 patients. Methods: A total of 773 cases, including 718 primary infection and unvaccinated COVID-19 patients and 55 controls. COVID-19 patients were assigned to severe and nonsevere groups according to disease severity, as well as survival and death groups according to prognosis. Serum samples were collected to measure the numbers of total lymphocytes and lymphocyte subsets. The differences among different severity groups were analyzed. Spearman correlation was performed to assess associations between lymphocyte subsets and disease severity and prognosis. Meanwhile, receiver operating characteristic (ROC) curves were also analyzed to find optimal cutoff points. Results: At admission, the severe group demonstrated significantly lower total lymphocyte counts and percentages, CD3+ and CD3+CD4+ T cell counts and percentages, CD3+CD8+ T cell counts, CD19+ B cell counts and CD56+ NK cell counts and percentages than the nonsevere group. Meanwhile, compared with the survival group, the death group also had lower total lymphocyte counts and percentages, CD3+, CD3+CD4+ and CD3+CD8+ T cell counts. Additionally, differences in these parameters were also noticed within four weeks after admission. Furthermore, Spearman analysis reported that disease severity was negatively correlated with lymphocyte counts and percentages, CD3+, CD3+CD4+ and CD3+CD8+ T cell counts, CD3+ and CD3+CD4+ T cell percentages (r=-0.166, -0.179, -0.173, -0.186, -0.127, -0.117, -0.149, respectively)(all P<0.05). The prognosis of death was also negatively correlated with total lymphocyte counts and percentages, CD3+, CD3+CD4+ and CD3+CD8+ T cell counts (r=-0.125, -0.121, -0.123, -0.123, -0.091, respectively)(all P<0.05). Conclusion: In primary infection and unvaccinated COVID-19 patients total lymphocytes and T cell, B cell and NK cell subsets at COVID-19 onset play valuable roles in predicting disease severity and prognosis. Clinical trial registry: Chinese Clinical Trial Register ChiCTR2000034563.
The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?

Da-wei Sun,Dong Zhang,Run-hui Tian,Yang Li,Yu-shi Wang,Jie Cao,Ying Tang,Nan Zhang,Tao Zan,Lan Gao,Yan-zhu Huang,Chang-lei Cui,Dong-xuan Wang,Yang Zheng,Guo-yue Lv

DOI: https://doi.org/10.1016/j.cca.2020.05.027

IF: 6.314

2020-09-01

Clinica Chimica Acta

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>The underlying changes of peripheral blood inflammatory cells (PBICs) in COVID-19 patients are little known. Moreover, the risk factors for the underlying changes of PBICs and their predicting role in severe COVID-19 patients remain uncertain.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Material and Methods</h3><p>This retrospective study including two cohorts: the main cohort enrolling 45 patients of severe type serving as study group, and the secondary cohort enrolling 12 patients of no-severe type serving as control group. The PBICs analysis was based on blood routine and lymphocyte subsets. The inflammatory cell levels were compared among patients according to clinical classifications, disease-associated phases, as well as one-month outcomes.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Compared with patients of non-severe type, the patients of severe type suffered from significantly decreased counts of lymphocytes, eosinophils, basophils, but increased counts of neutrophils. These PBICs alterations got improved in recovery phase, but persisted or got worse in aggravated phase. Compared with patients in discharged group, the patients in un-discharged/died group suffered from decreased counts of total T lymphocytes, CD4+T lymphocytes, CD8+T lymphocytes, as well as NK cells at 2 weeks after treatment. Clinical classification-critically severe was the independently risk factor for lymphopenia (<em>OR=7.701, 95%CI:1.265-46.893, P=0.027</em>), eosinopenia (<em>OR=5.595, 95%CI:1.008-31.054, P=0.049</em>) and worse one-month outcome (<em>OR=8.984; 95%CI:1.021-79.061, P=0.048</em>).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Lymphopenia and eosinopenia may serve as predictors of disease severity and disease progression in COVID-19 patients, and enhancing the cellular immunity may contribute to COVID-19 treatment. Thus, PBICs might become a sentinel of COVID-19, and it deserves attention during COVID-19 treatment.</p>

medical laboratory technology
Determinants of neurological syndromes caused by varicella zoster virus (VZV)

Peter GE Kennedy,Trine H Mogensen

DOI: https://doi.org/10.1007/s13365-020-00857-w

2020-06-03

Journal of NeuroVirology

Abstract:Varicella zoster virus (VZV) is a pathogenic human herpes virus which causes varicella as a primary infection, following which it becomes latent in peripheral autonomic, sensory, and cranial nerve ganglionic neurons from where it may reactivate after decades to cause herpes zoster. VZV reactivation may also cause a wide spectrum of neurological syndromes, in particular, acute encephalitis and vasculopathy. While there is potentially a large number of coding viral mutations that might predispose certain individuals to VZV infections, in practice, a variety of host factors are the main determinants of VZV infection, both disseminated and specifically affecting the nervous system. Host factors include increasing age with diminished cell-mediated immunity to VZV, several primary immunodeficiency syndromes, secondary immunodeficiency syndromes, and drug-induced immunosuppression. In some cases, the molecular immunological basis underlying the increased risk of VZV infections has been defined, in particular, the role of POL III mutations, but in other cases, the mechanisms have yet to be determined. The role of immunization in immunosuppressed individuals as well as its possible efficacy in preventing both generalized and CNS-specific infections will require further investigation to clarify in such patients.

neurosciences,virology
Acute myelitis with multicranial neuritis caused by Varicella zoster virus: a case report

Qi Liu,Xiaomeng Zhou,Zhenfei Li

DOI: https://doi.org/10.1186/s12883-022-02571-y

2022-02-05

BMC Neurology

Abstract:Abstract Background Varicella zoster virus (VZV) can remain lifelong in the latent state in ganglionic neurons and adrenal glands after the initial infection. However, it can be reactivated anytime and can trigger several severe neurological manifestations such as encephalitis, meningitis, Ramsay-Hunt syndrome, cerebellitis, myelitis, and stroke. In addition, due to the diversity of clinical manifestations, clinical diagnosis of VZV can be difficult, especially in the absence of varicella. Here, we describe the case of a 52-year-old male who presented with symptoms of acute myelitis as well as polycranial neuritis, and was finally diagnosed with VZV infection through metagenomic next-generation sequencing (mNGS). Case presentation A 52-year-old male came to our hospital with complaint of headache, fever, weakness of right lower limb, abdominal distension, and hearing loss. T2-weighted MRI revealed a hyperintense lesion in the spinal cord extending from T8 to T11. In addition, enhanced MRI showed small patches and strips hyperintensities in both the spinal cord and meninges. Plain abdominal radiographs and abdominal computed tomography (CT) scan displayed air-fluid levels and incomplete bowel obstruction. Moreover, electrophysiological evaluation of the peripheral neuropathy in the extremities was found to be normal. Finally, by using metagenomic next-generation sequencing (mNGS) we found that the copy number of VZV DNA in cerebrospinal fluid (CSF) was significantly increased and IgG antibody against VZV in CSF was also noted to be positive. Hence, VZV infection was identified in patient’s central neuron system. Finally, after a few days of low dose steroid treatment, the patient's symptoms were found to be significantly improved. Conclusions The findings indicate that we should pay proper attention to the various symptoms caused by VZV infection due to the clinical heterogeneity, especially in the absence of cutaneous lesions.

clinical neurology
P1525: CLINICAL PROGNOSTIC SCORING MODEL FOR VIRAL ENCEPHALITIS IN PATIENTS UNDERGOING ALLO-HAEMATOPOIETIC STEM CELL TRANSPLANTATION

Yu-Chen He,Chen-Hua Yan,Yuan Kong,Xiao-Lu Zhu,Hai-Xia Fu,Yun He,Feng-Rong Wang,Yuan-Yuan Zhang,Xiao-Dong Mo,Wei Han,Jing-Zhi Wang,Yu Wang,Huan Chen,Yu-Hong Chen,Xiang-Yu Zhao,Ying-Jun Chang,Lan-Ping Xu,Kai-Yan Liu,Xiao-Jun Huang,Xiao-Hui Zhang

DOI: https://doi.org/10.1097/01.hs9.0000972976.88590.63

2023-01-01

HemaSphere

Abstract:Topic: 30. Infections in hematology (incl. supportive care/therapy) Background: As a radical therapy for haematological malignancies, haematopoietic stem cell transplantation (HSCT) has been widely performed in recent years. However, numerous complications still threaten the outcomes of post-transplant patients, including viral encephalitis (VE), which is a common but fatal central nervous system infection in immunocompromised individuals. Currently, there is still a lack of research on the prognosis of patients with VE after HSCT. Aims: The principal objective of this project was to establish a clinical prognostic scoring model to recognize post-transplant VE patients who are at a higher risk for death. Methods: In our study, 115 VE patients who underwent HSCT from 2014 to 2021 were divided into derivation and validation cohorts containing 69 and 46 patients, respectively. The clinical baseline data were analysed first. Subsequently, we screened out the prognostic factors in the derivation cohort using Cox regression analysis and then constructed a clinical prognostic scoring model. After grouping patients in the derivation and validation cohorts according to their different prognoses, we estimated the performance of this model with the Kaplan-Meier method, the area under the receiver operating characteristic curve (AUC), the calibration plot and the decision curve analysis (DCA). Results: We performed univariate Cox regression analysis to select prognostic predictors for VE after HSCT. Variables with p<0.10 were subsequently included in the multivariate analysis. Patients with unconsciousness (p=0.012; RR, 3.416; 95%CI, 1.307-8.930), paresthesia (p=0.011; RR, 3.807; 95%CI, 1.354-10.623), cytomegalovirus (CMV) positivity in cerebrospinal fluid (p=0.014; RR, 5.311; 95%CI, 1.403-20.103) and grade III to IV acute graft-versus-host disease (aGVHD) (p=0.043; RR, 2.657; 95%CI, 1.031-6.848) were identified as predictors for our clinical prognostic scoring model. According to the regression coefficient, a score of 1 was assigned to each predictor. The overall scores of this model ranged from 0 to 4, upon which a 2-category scoring model was established: low (score of 0-1) and high (score of 2-4). In the derivation cohort, the corresponding 16-month OS according to each risk group was 78.7% (low) and 13.9% (high) (p<0.001). The AUC was 0.818 (95%CI, 0.724-0.913), showing good discrimination power. In the validation cohort, the 16-month OS results for the risk groups were 85.3% (low) and 20.0% (high) (p<0.001), and the AUC was 0.793 (95%CI, 0.644-0.942). Furthermore, we performed calibration plots which demonstrated good consistency among the prediction results in the derivation and validation cohorts. DCA exhibited the good accuracy of this model, and patients could benefit from its application. Summary/Conclusion: VE is a common but fatal complication of HSCT. Our study established a clinical prognostic scoring model to select high-risk post-transplantation patients with VE and validated its discrimination, calibration and clinical practicality. Keywords: CNS, Infection, Prognostic factor, Allogeneic hematopoietic stem cell transplant

Immune changes and their relationship with prognosis in patients with varicella-zoster virus encephalitis/meningitis.

Cerebrospinal Fluid Proteomics in Meningitis Patients with Reactivated Varicella Zoster Virus

Factors Predictive of Varicella Zoster Virus Encephalitis/Meningitis: A Single-Center, Retrospective Study

Dynamic Immune Landscape and VZV-Specific T Cell Responses in Patients with Herpes Zoster and Postherpetic Neuralgia

Meningitis/meningoencephalitis Caused by Varicella Zoster Virus Reactivation: a Retrospective Single-Center Case Series Study.

The Correlation Between Clinical Severity and Lymphocyte Subsets or Immunoglobulin Subtypes in Patients with Herpes Zoster

Serum Immunoglobulin G Level and Neutrophils to Lymphocytes Ratio Associated with the Prognosis of Neuromyelitis Optica Spectrum Disorder.

Single-cell Immune Profiling and Validation of PBMCs in the Onset of and Recovery from Herpes Zoster

Analysis of risk factors and prediction model construction for varicella encephalitis in children: A retrospective cohort study

Dynamic Behavior of Lymphocyte Subgroups Correlates with Clinical Outcomes in Human H7N9 Infection.

Varicella-Zoster Virus Meningitis and Encephalitis: An Understated Cause of Central Nervous System Infections

Challenges in Diagnosing Varicella-Zoster Virus Encephalitis in an Immunocompromised Patient

Varicella‑zoster virus‑associated meningitis followed peripheral facial palsy: A case report

The Role of Varicella Zoster Virus (VZV) in Central Nervous System Infectious Syndromes

Effect of varicella‐zoster virus infection and antiviral treatment on the risk for dementia: A meta‐analysis of observational studies

Assessment of the humoral immune status of varicella-zoster virus in patients with diffuse connective tissue diseases

Dynamic Characteristics of Lymphocyte Subsets and Their Predictive Value for Disease Progression and Prognosis in Primary Infection and Unvaccinated COVID-19 Patients

The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?

Determinants of neurological syndromes caused by varicella zoster virus (VZV)

Acute myelitis with multicranial neuritis caused by Varicella zoster virus: a case report

P1525: CLINICAL PROGNOSTIC SCORING MODEL FOR VIRAL ENCEPHALITIS IN PATIENTS UNDERGOING ALLO-HAEMATOPOIETIC STEM CELL TRANSPLANTATION